HPV Vaccination Rates Remain Low Among Swiss Adults Despite Cancer Prevention Benefits
Human papillomavirus (HPV) is the most common sexually transmitted infection globally and a significant cause of several cancers. While HPV vaccination is highly effective, a recent study from the University of Zurich reveals that adult vaccination rates in Switzerland remain surprisingly low, with just over one in four adults aged 18 to 45 having received at least one dose of the vaccine. This contrasts with high vaccination rates among adolescents, where uptake reached 71% for girls and 49% for boys between 2020, and 2022.
Age and Gender Disparities in Vaccination
The study, published in JAMA Network Open, highlights a clear pattern of disparities. Vaccination rates decline significantly with age, dropping from nearly 59% among those aged 18 to 26 to around 16% for those aged 27 to 45. A substantial gender gap likewise exists, with nearly 43% of women vaccinated compared to only about 12% of men. These differences are attributed to the initial recommendation of the HPV vaccine solely for adolescent girls and its relatively late introduction for boys in 2015 .
Knowledge, Attitudes, and Vaccination Decisions
The research categorizes individuals into three groups based on their HPV knowledge and attitudes toward vaccination. Approximately 41% of those well-informed about HPV are vaccinated, compared to just under 14% among those with moderate knowledge, and only 8% in the group with limited knowledge. This underscores the strong correlation between understanding HPV and its prevention, and the likelihood of getting vaccinated .
The Role of Healthcare Provider Recommendations
A crucial factor influencing vaccination decisions is the recommendation from a healthcare professional. Many vaccinated individuals reported that a physician’s advice was instrumental in their choice. Conversely, over half of unvaccinated individuals stated they had never received such a recommendation. This highlights a significant opportunity for healthcare providers to proactively discuss HPV vaccination with their patients .
Addressing Barriers and Improving Outreach
Even among those with limited knowledge about HPV, approximately half remain open to vaccination. Among the well-informed, around 60% of unvaccinated individuals would consider getting vaccinated if provided with more information. These findings suggest that targeted information campaigns and tailored communication strategies are essential to improve adult HPV vaccination rates. Specifically, conversations within clinical settings offer a valuable opportunity to address concerns and build trust .
Understanding HPV and Vaccination
HPV is transmitted through sexual contact and can cause various cancers, including cervical, anal, and oropharyngeal cancers . Vaccination protects against infection with the most common high-risk HPV types. In Switzerland, the HPV vaccine has been recommended for girls and young women since 2007 and for boys and young men since 2015. Catch-up vaccination is available for women up to age 45 .
Despite the proven benefits of HPV vaccination, uptake among adults remains a public health concern. Addressing knowledge gaps, promoting healthcare provider recommendations, and implementing targeted outreach programs are crucial steps toward increasing vaccination rates and reducing the burden of HPV-related cancers.